Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Oppenheimer
Oppenheimer analyst Mark Breidenbach lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
